Tytuł artykułu
Autorzy
Wybrane pełne teksty z tego czasopisma
Identyfikatory
Warianty tytułu
Języki publikacji
Abstrakty
An ultra-performance liquid chromatography–tandem mass spectrometry (UPLC–MS/MS) method was established to determine hirsutine and hirsuteine in rat plasma. Pharmacokinetics of hirsutine and hirsuteine in rats after intravenous or oral administration has been investigated using this developed UPLC–MS/MS method, and bioavailability of the two drugs was calculated. Diazepam was used as internal standard, and UPLC BEH column (2.1 mm × 50 mm, 1.7 μm) was used at temperature of 40 °C. The mobile phase was composed of acetonitrile and water (containing 0.1% formic acid) at a gradient elution flow rate of 0.4 mL/min. Nitrogen was used as desolvation gas (800 L/h) and conical gas (50 L/h). The multiple reaction monitoring (MRM) model was applied to quantitatively analyze hirsutine m/z 369 → 226, hirsuteine m/z 367 → 169.9, and diazepam (internal standard) m/z 285.1 → 193.3. Rat plasma samples were deproteinized using acetonitrile prior to UPLC–MS/MS analysis. Within the concentration range of 1–200 ng/mL, the linearity of hirsutine and hirsuteine in plasma was good (r > 0.995), and the lower limit of quantitation was 1 ng/mL. Relative standard deviations of intra-day precision for hirsutine and hirsuteine were ≤6.1% and ≤5.9%, respectively, and those of inter-day precision were ≤6% and ≤7.7%. Accuracy for hirsutine and hirsuteine ranged between 92.3% and 104.8%. Bioavailability of hirsutine and hirsuteine was 4.4% and 8.2%, respectively. The method is sensitive and fast with good selectivity and was successfully applied in the pharmacokinetic studies after intravenous and oral administration of hirsutine and hirsuteine.
Słowa kluczowe
Czasopismo
Rocznik
Tom
Strony
99--104
Opis fizyczny
Bibliogr. 37 poz., rys., tab.
Twórcy
autor
- Department of Pharmacy, The People's Hospital of Lishui, Lishui 323000, China
autor
- Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China
autor
- The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China
autor
- Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China
autor
- Department of Pharmacy, The People's Hospital of Lishui, Lishui 323000, China
autor
- Analytical and Testing Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China
autor
- Analytical and Testing Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China
autor
- Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China
Bibliografia
- [1] Ndagijimana, A.; Wang, X. M.; Pan, G. X.; Zhang, F.; Feng, H.; Olaleye, O. Fitoterapia 2013, 86, 35–47.
- [2] Zhang, J. G.; Geng, C. A.; Huang, X. Y.; Chen, X. L.; Ma, Y. B.; Zhang, X. M.; Chen, J. J. Eur. J. Mass Spectrom. 2017, 23, 11–21.
- [3] Li, Y. L.; Yang, W. Q.; Zhu, Q. J.; Yang, J. G.; Wang, Z. BioSci. Trends 2015, 9, 237–244.
- [4] Qi, W.; Yue, S. J.; Sun, J. H.; Simpkins, J. W.; Zhang, L.; Yuan, D. J. Asian Nat. Prod. Res. 2014, 16, 876–883.
- [5] Ho, T. Y.; Tang, N. Y.; Hsiang, C. Y.; Hsieh, C. L. Phytomedicine 2014, 21, 893–900.
- [6] Tang, N. Y.; Lin, Y. W.; Ho, T. Y.; Cheng, C. Y.; Chen, C. H.; Hsieh, C. L. Evidence-Based Complementary Altern. Med. 2017, 2017, 9732854.
- [7] Hsu, H. C.; Tang, N. Y.; Liu, C. H.; Hsieh, C. L. Evidence-Based Complementary Altern. Med. 2013.
- [8] Pan, H. Q.; Yang, W. Z.; Zhang, Y. B.; Yang, M.; Feng, R. H.; Wu, W. Y.; Guo, D. A. Anal. Bioanal. Chem. 2015, 407, 6057–6070.
- [9] Lu, W.; Yang, F.; Wang, S. Acta Chromatogr. 2012, 24 643–651.
- [10] Li, S. P.; Cheng, X. M.; Wang, C. H. J. Ethnopharmacol. 2017, 203, 127–162.
- [11] Cheng, H. S.; Ton, S. H.; Kadir, K. A. Phytochem. Rev. 2017, 16, 159–193.
- [12] Wang, X.; Zheng, M.; Liu, J.; Qiao, Z.; Liu, W.; Feng, F. Xenobiotica 2017, 47, 479–487.
- [13] Ge, Z.; Xie, Y.; Liang, Q.; Wang, Y.; Luo, G. Evid. Based Complement. Alternat. Med. 2014, 2014, 167253.
- [14] Cai, J.; Lin, C.; Ma, J.; Hu, L.; Lin, G.; Wang, X. J. Chromatogr. Sci. 2014, 52, 661–665.
- [15] Wu, Y. T.; Lin, L. C.; Tsai, T. H. Biomed. Chromatogr. 2014, 28, 439–445.
- [16] Kushida, H.; Fukutake, M.; Tabuchi, M.; Katsuhara, T.; Nishimura, H.; Ikarashi, Y.; Kanitani, M.; Kase, Y. Biomed. Chromatogr. 2013, 27, 1647–1656.
- [17] Wang, X.; Zheng, M.; Liu, J.; Huang, Z.; Bai, Y.; Ren, Z.; Wang, Z.; Tian, Y.; Qiao, Z.; Liu, W.; Feng, F. J. Ethnopharmacol. 2017, 209, 175–183.
- [18] Zhao, L.; Zang, B.; Qi, W.; Chen, F.; Wang, H.; Kano, Y.; Yuan, D. Fitoterapia 2016, 111, 49–57.
- [19] Gai, Y.; Chen, H.; Liu, W.; Feng, F.; Xie, N. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2014, 972, 22–28.
- [20] Wang, W.; Luo, S.; Chen, Y.; Li, B.; Hattori, M. Anal. Sci. 2016, 32, 705–707.
- [21] Ma, J.; Cai, J.; Lin, G.; Chen, H.; Wang, X.; Wang, X.; Hu, L. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2014, 959, 10–15.
- [22] Liu, M.; Su, X.; Li, G.; Zhao, G.; Zhao, L. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2015, 1006, 8–15.
- [23] Ai, Y.; Wu, Y.; Wang, F.; Ma, W.; Bian, Q.; Lee, D. Y.; Dai, R. J. Mass Spectrom. 2015, 50, 567–577.
- [24] Health, U.D.o.; F. Human services; C.f.D.E. Drug Administration; C.f.V.m. Research Fed. Regist. 2001, 66, 206–207.
- [25] Fang, B.; Bao, S.; Wang, S.; Chen, M.; Chen, B.; Su, K.; Wen, C.; Zhou, Y.; Wang, X.; Jin, Y. Biomed. Chromatogr. 2017, 31.
- [26] Wang, J.; Zhao, T.; Kong, J.; Peng, H.; Lv, P.; Li, J.; Cao, X.; Zhang, S. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2017, 1061–1062, 270–274.
- [27] Jiang, Y.; Zhou, H.; Su, K.; Xu, M. Z.; Chen, B. B.; Chen, D. X.; Wen, C. C.; Wu, B.; Luo, X. H.; Wang, X. Q. Lat. Am. J. Pharm. 2016, 35, 2261–2266.
- [28] Cai, J. Z.; Huang, Z. Z.; Chen, X. L.; Xu, R. A.; He, H. Z.; Lin, C. L.; Lin, G. Y.; Wang, X. Q. Lat. Am. J. Pharm. 2012, 31, 388–393.
- [29] Bao, S. H.; Geng, P. W.; Yang, S. P.; Liu, Z. Z.; Lin, Y. Y.; Ma, J. S.; Wen, C. C.; Lin, G. Y.; Zou, R. M. Int. J. Clin. Exp. Med. 2016, 9, 6309–6315.
- [30] Lin, G. Y.; Ma, J. S.; Lin, C. L.; Hu, L. F.; Wang, X. Q. J. Liq. Chromatogr. Relat. Technol. 2014, 37, 2506–2514.
- [31] Zhang, Q.; Wen, C.; Xiang, Z.; Ma, J.; Wang, X. J. Pharm. Biomed. Anal. 2014, 90, 134–138.
- [32] Ye, W.; Chen, R.; Sun, W.; Huang, C.; Lin, X.; Dong, Y.; Wen, C.; Wang, X. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2017, 1060, 144–149.
- [33] Gullick, D. R.; Mott, K. B.; Bartlett, M. G. Biomed. Chromatogr. 2016, 30, 772–789.
- [34] Yang, X. K.; Ma, Y. J.; Li, N.; Cai, H. J.; Bartlett, M. G. Anal. Chem. 2017, 89, 813–821.
- [35] Wang, S. H.; Wu, H. Y.; Huang, X. L.; Geng, P. W.; Wen, C. C.; Ma, J. S.; Zhou, Y. F.; Wang, X. Q. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2015, 990, 118–124.
- [36] Ma, J. S.; Wang, S. H.; Huang, X. L.; Geng, P. W.; Wen, C. C.; Zhou, Y. F.; Yu, L. S.; Wang, X. Q. J. Pharm. Biomed. Anal. 2015, 111, 131–137.
- [37] Wen, C.; Zhang, Q.; He, Y.; Deng, M.; Wang, X.; Ma, J. Acta Chromatogr. 2015, 27, 81–91.
Uwagi
PL
Opracowanie rekordu w ramach umowy 509/P-DUN/2018 ze środków MNiSW przeznaczonych na działalność upowszechniającą naukę (2019).
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-3d2aff93-0d0b-4f86-851a-26ed91ac6a41